~~<i id='C0828CCF77'><strike id='C0828CCF77'><tt id='C0828CCF77'><pre id='C0828CCF77'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

author：entertainment 2025-08-12 13:38:42 - browse：6

Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history.

This week Biogen said it would no longer sell or study the medicine, which first won approval in 2021, ending an era for one of biotech’s storied companies and leaving the rest of the industry to piece together the lessons of a would-be blockbuster that never took off.

STAT reporters took a stab at the Aduhelm legacy — for biotech, Biogen, and Alzheimer’s research — on a recent episode of the Readout LOUD. Here’s an edited transcript of that conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Investment in vaccine development is lagging, report finds

Wikipedia

hotspot

Wikipedia

focus

hotspot

1:27PoliceofficersstandguardoutsidePortlandPortbeforethefirstasylumseekersarrivetoboardtheBibbyStock

WSS

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Democratic lawmaker calls for 'well

The UK government moves asylum

Zyn nicotine pouches become unlikely player in latest culture war

Wikipedia

Wikipedia

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

Why you shouldn’t ask, “What country has the best health care?”

Medicare details structure of new drug price negotiation program

Mississippi candidates for statewide offices square off in party primaries

Medicare proposal to cover medical devices draws a mixed reaction

Boston competes with Raleigh

New air purifier tech could be key to improving indoor air quality

Merck, Johnson & Johnson CEOs will testify on high drug prices

Peter Hotez and the public health issue of online harassment

Boeing's 1st astronaut flight bumped into next year, more repairs needed

hotspot

Vertex non

Investment in vaccine development is lagging, report finds

NYC plans to house migrants on an island in the East River

Wegovy leads to weight loss. Can it treat depression, too?

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Philips to halt sales of sleep apnea machines in U.S.

Wikipedia

focus

focus

hotspot